Susanna Kullberg

2.2k total citations
58 papers, 1.3k citations indexed

About

Susanna Kullberg is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Susanna Kullberg has authored 58 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Physiology, 40 papers in Pulmonary and Respiratory Medicine and 17 papers in Molecular Biology. Recurrent topics in Susanna Kullberg's work include Sarcoidosis and Beryllium Toxicity Research (45 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (40 papers) and Autoimmune and Inflammatory Disorders (7 papers). Susanna Kullberg is often cited by papers focused on Sarcoidosis and Beryllium Toxicity Research (45 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (40 papers) and Autoimmune and Inflammatory Disorders (7 papers). Susanna Kullberg collaborates with scholars based in Sweden, United States and Australia. Susanna Kullberg's co-authors include Johan Grünewald, Anders Eklúnd, Elizabeth V. Arkema, Johan Askling, Brun Ulfhake, Marios Rossides, Hans Johnson, Vania Ramírez-León, Esbjörn Bergman and Erik Edström and has published in prestigious journals such as PLoS ONE, Scientific Reports and Brain Research.

In The Last Decade

Susanna Kullberg

55 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susanna Kullberg Sweden 20 843 660 403 176 109 58 1.3k
Tahir Ahmed United States 22 597 0.7× 631 1.0× 199 0.5× 95 0.5× 45 0.4× 77 1.4k
Elske Hoitsma Netherlands 18 1.0k 1.2× 585 0.9× 191 0.5× 112 0.6× 139 1.3× 38 1.5k
Kenji Minoguchi Japan 21 2.0k 2.3× 922 1.4× 304 0.8× 127 0.7× 39 0.4× 55 2.6k
Carole Planès France 28 522 0.6× 1.0k 1.5× 866 2.1× 124 0.7× 20 0.2× 64 2.1k
Ynuk Bossé Canada 23 1.0k 1.2× 870 1.3× 347 0.9× 31 0.2× 37 0.3× 92 1.6k
Mieke Timmers Netherlands 18 1.2k 1.4× 910 1.4× 315 0.8× 174 1.0× 10 0.1× 22 1.8k
Jin Huang China 21 195 0.2× 497 0.8× 510 1.3× 280 1.6× 39 0.4× 70 2.2k
Wendy Surs United States 9 868 1.0× 439 0.7× 154 0.4× 78 0.4× 104 1.0× 12 1.5k
Yoshitaka Hirayama Japan 18 374 0.4× 244 0.4× 270 0.7× 41 0.2× 173 1.6× 37 1.1k
Tsuyoshi Ishida Japan 17 262 0.3× 266 0.4× 278 0.7× 77 0.4× 121 1.1× 54 1.2k

Countries citing papers authored by Susanna Kullberg

Since Specialization
Citations

This map shows the geographic impact of Susanna Kullberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susanna Kullberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susanna Kullberg more than expected).

Fields of papers citing papers by Susanna Kullberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susanna Kullberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susanna Kullberg. The network helps show where Susanna Kullberg may publish in the future.

Co-authorship network of co-authors of Susanna Kullberg

This figure shows the co-authorship network connecting the top 25 collaborators of Susanna Kullberg. A scholar is included among the top collaborators of Susanna Kullberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susanna Kullberg. Susanna Kullberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Darlington, Pernilla, et al.. (2025). Seasonal variation in Swedish sarcoidosis patients with severe hypercalcemia. Scientific Reports. 15(1). 5312–5312.
2.
Rossides, Marios, Susanna Kullberg, & Elizabeth V. Arkema. (2024). History and Familial Aggregation of Immune-Mediated Diseases in Sarcoidosis. CHEST Journal. 166(5). 1082–1092. 2 indexed citations
3.
Rossides, Marios, et al.. (2024). Elevated serum angiotensin converting enzyme correlates with specific HLA-DRB1 alleles and extrapulmonary manifestations in sarcoidosis. Respiratory Medicine and Research. 86. 101142–101142. 2 indexed citations
4.
Patasova, Karina, et al.. (2024). Sarcoidosis shares susceptibility loci with autoimmune disorders and cancers. PA2490–PA2490. 1 indexed citations
5.
Bobbio, Emanuele, Christian L. Polte, Clara Hjalmarsson, et al.. (2023). Clinical Outcomes and Predictors of Long‐Term Survival in Patients With and Without Previously Known Extracardiac Sarcoidosis Using Machine Learning: A Swedish Multicenter Study. Journal of the American Heart Association. 12(15). e029481–e029481. 4 indexed citations
6.
Darlington, Pernilla, Jonas Melin, Natalia V. Rivera, et al.. (2023). Peripheral blood lymphopenia in sarcoidosis associates with HLA-DRB1 alleles but not with lung immune cells and organ involvement. Clinical & Experimental Immunology. 213(3). 357–362. 3 indexed citations
7.
Rossides, Marios, Susanna Kullberg, Daniela Di Giuseppe, et al.. (2021). Infection risk in sarcoidosis patients treated with methotrexate compared to azathioprine: A retrospective ‘target trial’ emulated with Swedish real‐world data. Respirology. 26(5). 452–460. 24 indexed citations
8.
Lepzien, Rico, Sang Liu, Paulo Czarnewski, et al.. (2021). Monocytes in sarcoidosis are potent tumour necrosis factor producers and predict disease outcome. European Respiratory Journal. 58(1). 2003468–2003468. 31 indexed citations
9.
Rossides, Marios, Susanna Kullberg, Johan Grünewald, et al.. (2021). Risk and predictors of heart failure in sarcoidosis in a population-based cohort study from Sweden. Heart. 108(6). 467–473. 14 indexed citations
10.
Wahlström, Jan, et al.. (2021). Bronchoalveolar lavage fluid cell subsets associate with the disease course in Löfgren's and non-Löfgren's sarcoidosis patients. Respiratory Medicine. 186. 106521–106521. 4 indexed citations
11.
Rossides, Marios, Susanna Kullberg, Johan Askling, et al.. (2020). Are infectious diseases risk factors for sarcoidosis or a result of reverse causation? Findings from a population-based nested case–control study. European Journal of Epidemiology. 35(11). 1087–1097. 12 indexed citations
12.
Rossides, Marios, Susanna Kullberg, Anders Eklúnd, et al.. (2020). Risk of first and recurrent serious infection in sarcoidosis: a Swedish register-based cohort study. European Respiratory Journal. 56(3). 2000767–2000767. 29 indexed citations
13.
Rossides, Marios, Susanna Kullberg, Anders Eklúnd, Johan Grünewald, & Elizabeth V. Arkema. (2019). Sarcoidosis diagnosis and treatment in Sweden: A register-based assessment of variations by region and calendar period. Respiratory Medicine. 161. 105846–105846. 16 indexed citations
14.
Hagemann-Jensen, Michael, Maria Needhamsen, Lara Kular, et al.. (2019). Tobacco smoking induces changes in true DNA methylation, hydroxymethylation and gene expression in bronchoalveolar lavage cells. EBioMedicine. 46. 290–304. 46 indexed citations
15.
Rossides, Marios, Susanna Kullberg, Johan Askling, et al.. (2018). Sarcoidosis mortality in Sweden: a population-based cohort study. European Respiratory Journal. 51(2). 1701815–1701815. 63 indexed citations
16.
Rossides, Marios, Johan Grünewald, Anders Eklúnd, et al.. (2018). Familial aggregation and heritability of sarcoidosis: a Swedish nested case−control study. European Respiratory Journal. 52(2). 1800385–1800385. 52 indexed citations
17.
Parasa, Venkata Ramanarao, Helena Forsslund, D. Lorenz, et al.. (2017). Enhanced CD8+ cytolytic T cell responses in the peripheral circulation of patients with sarcoidosis and non-Löfgren's disease. Respiratory Medicine. 138. S38–S44. 20 indexed citations
18.
Kaiser, Ylva, Rico Lepzien, Susanna Kullberg, et al.. (2016). Expanded lung T-bet+RORγT+CD4+T-cells in sarcoidosis patients with a favourable disease phenotype. European Respiratory Journal. 48(2). 484–494. 55 indexed citations
19.
Öckinger, Johan, Michael Hagemann-Jensen, Susanna Kullberg, et al.. (2016). T-cell activation and HLA-regulated response to smoking in the deep airways of patients with multiple sclerosis. Clinical Immunology. 169. 114–120. 18 indexed citations
20.
Edström, Erik, Susanna Kullberg, Ming Yu, Huaiyu Zheng, & Brun Ulfhake. (2004). MHC Class I, β2 microglobulin, and the INF‐γ receptor are upregulated in aged motoneurons. Journal of Neuroscience Research. 78(6). 892–900. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tahir Ahmed Breakdown of academic impact, for papers by Elske Hoitsma Breakdown of academic impact, for papers by Kenji Minoguchi Breakdown of academic impact, for papers by Carole Planès Breakdown of academic impact, for papers by Ynuk Bossé Breakdown of academic impact, for papers by Mieke Timmers Breakdown of academic impact, for papers by Jin Huang Breakdown of academic impact, for papers by Wendy Surs Breakdown of academic impact, for papers by Yoshitaka Hirayama Breakdown of academic impact, for papers by Tsuyoshi Ishida
Rankless by CCL
2026